[1]潘蕾蕾,江卫兵,方　芳,等.MiR-152-3p靶向PIK3CA基因对乳腺癌细胞生物学特性的调控及其机制[J].新乡医学院学报,2019,36(12):1130-1136.[doi:10.7683/xxyxyxb.2019.12.007]
　PAN Lei-lei,JIANG Wei-bing,FANG Fang,et al.Regulation and mechanism of miR-152-3p targeting PIK3CA gene on biological characteristics of breast cancer cells[J].Journal of Xinxiang Medical University,2019,36(12):1130-1136.[doi:10.7683/xxyxyxb.2019.12.007]
点击复制

MiR-152-3p靶向PIK3CA基因对乳腺癌细胞生物学特性的调控及其机制
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年12
页码:
1130-1136
栏目:
临床研究
出版日期:
2019-12-12

文章信息/Info

Title:
Regulation and mechanism of miR-152-3p targeting PIK3CA gene on biological characteristics of breast cancer cells
作者:
潘蕾蕾1; 江卫兵1; 方　芳2; 陈剑平2; 殷照才2
（1.宣城市中心医院心胸乳腺外科，安徽　宣城　242000；2.皖南医学院弋矶山医院甲状腺乳腺外科，安徽　皖南　241001）
Author(s):
PAN Lei-lei1; JIANG Wei-bing1; FANG Fang2; CHEN Jian-ping2; YIN Zhao-cai2
(1.Department of Cardiothoracic and Breast Surgery，Xuancheng Central Hospital，Xuancheng 242000，Anhui Province，China; 2.Department of Thyroid and Breast Surgery，Yijishan Hospital of Wannan Medical College，Wannan 241001，Anhui Province，China)
关键词:
乳腺癌; miR-152-3p; PIK3CA; 丝裂原活化蛋白激酶信号通路; 细胞增殖
Keywords:
breast cancer;  miR-152-3p;  PIK3CA;  mitogen activated protein kinase signaling pathway;  cell proliferation
分类号:
R737.9
DOI:
10.7683/xxyxyxb.2019.12.007
文献标志码:
A
摘要:
目的　探讨miR-152-3p靶向PIK3CA基因对乳腺癌细胞生物学特性的调控及机制。方法　选取2016年1月至2017年7月宣城市中心医院保存的乳腺癌组织和相应的正常乳腺组织（距肿瘤边缘>5 cm）标本各50例，培养乳腺癌MCF-7细胞和正常乳腺上皮细胞MCF-10A，采用反转录定量聚合酶链反应（qRT-PCR）检测乳腺癌组织、正常乳腺组织、MCF-7细胞及MCF-10A细胞中miR-152-3p及PIK3CA mRNA表达。培养MCF-7细胞，待细胞融合度达30%～50%时将细胞分为空白组、阴性对照组、miR-152-3p mimic组、miR-152-3p inhibitor组、si-PIK3CA组和miR-152-3p inhibitor+si-PIK3CA组，空白组细胞不转染任何序列，阴性对照组细胞转染miR-152-3p阴性对照质粒，miR-152-3p mimic组细胞转染miR-152-3p mimic质粒，miR-152-3p inhibitor组细胞转染miR-152-3p inhibitor质粒，si-PIK3CA组细胞转染si-PIK3CA质粒，miR-152-3p inhibitor+si-PIK3CA组细胞共转染miR-152-3p inhibitor质粒和si-PIK3CA，转然后继续培养24～48 h；采用Western blot法检测各组MCF-7细胞中PIK3CA、细胞外信号调节激酶（ERK）、c-Jun氨基末端激酶（JNK）、p38和E-cadherin蛋白表达，四甲基偶氮唑盐法检测各组MCF-7细胞增殖活性，划痕实验检测各组MCF-7细胞迁移能力，Transwell侵袭实验检测各组MCF-7细胞侵袭能力。结果　乳腺癌组织中miR-152-3p相对表达量显著低于正常乳腺组织，PIK3CA mRNA相对表达量显著高于正常乳腺组织（P<0.05）。MCF-7细胞中miR-152-3p相对表达量显著低于MCF-10A细胞，PIK3CA mRNA相对表达量显著高于MCF-10A细胞（P<0.05）。与空白组和阴性对照组比较，miR-152-3p mimic组和si-PIK3CA组MCF-7细胞中PIK3CA、p38、ERK、JNK和E-cadherin蛋白相对表达量显著降低，miR-152-3p inhibitor组MCF-7细胞中PIK3CA、p38、ERK、JNK和E-cadherin蛋白相对表达量显著升高（P<0.05）。miR-152-3p inhibitor+si-PIK3CA组与空白组和阴性对照组MCF-7细胞中PIK3CA、p38、ERK、JNK和E-cadherin蛋白相对表达量比较差异无统计学意义（P>0.05）。细胞增殖能力实验结果显示，48、72、96 h时，miR-152-3p mimic组和si-PIK3CA组MCF-7细胞增殖能力显著低于空白组和阴性对照组，miR-152-3p inhibitor组MCF-7细胞增殖能力显著高于空白组和阴性对照组（P<0.05）；48、72、96 h时，miR-152-3p inhibitor+si-PIK3CA组与空白组和阴性对照组MCF-7细胞增殖能力比较差异均无统计学意义（P>0.05）。划痕实验和Transwell侵袭实验结果显示，空白组与阴性对照组MCF-7细胞迁移和侵袭能力比较差异无统计学意义（P>0.05）；与空白组和阴性对照组比较，miR-152-3p mimic组和si-PIK3CA组MCF-7细胞迁移和侵袭能力显著降低，miR-152-3p inhibitor组MCF-7细胞迁移和侵袭能力显著增强（P<0.05）；miR-152-3p inhibitor+si-PIK3CA组与空白组和阴性对照组MCF-7细胞迁移和侵袭能力比较差异无统计学意义（P>0.05）。结论　miR-152-3p在乳腺癌组织中低表达，miR-152-3p可能参与了乳腺癌的发生与发展，miR-152-3p可能通过抑制PIK3CA表达而抑制MAPK信号通路的激活，进而抑制乳腺癌细胞的生长、增殖及侵袭转移。
Abstract:
Objective　To investigate the regulation and mechanism of miR-152-3p targeting PIK3CA gene on biological characteristics of breast cancer cells.Methods　Fifty samples of breast cancer tissues and 50 samples of corresponding normal breast tissues (more than 5 cm from the edge of the tumor) were collected in Xuancheng Central Hospital from January 2016 to July 2017.Breast cancer MCF-7 cells and normal breast epithelium MCF-10A cells were cultured.The mRNA expression of miR-152-3p and PIK3CA in breast cancer tissues，normal breast tissues，MCF-7 cells and MCF-10A cells were detected by reverse transcription quantitative polymerase chain reaction (qRT-PCR).When the fusion degree of MCF-7 cells reached 30%-50%，the cells were divided into blank group，negative control group，miR-152-3p mimic group，miR-152-3p inhibitor group，si-PIK3CA group and miR-152-3p inhibitor+si-PIK3CA group.The cells in the blank group were not transfected with any sequence; the cells in the negative control group，miR-152-3p mimic group，miR-152-3p inhibitor group and si-PIK3CA group were transfected with miR-152-3p negative control plasmids，miR-152-3p mimic plasmids，miR-152-3p inhibitor plasmids and si-PIK3CA plasmids，respectively; the cells in the miR-152-3p inhibitor+si-PIK3CA group were transfected with miR-152-3p inhibitor plasmids and si-PIK3CA.Then the cells were cultured for 24-48 hours.The expressions of PIK3CA，extracellular signal-regulated kinase (ERK)，Jun N-terminal kinase (JNK)，p38 and E-cadherin protein in MCF-7 cells were detected by Western blot.The proliferation activity of MCF-7 cells was detected by methyl thiazolyl tetrazolium method.The migration ability of MCF-7 cells was detected by scratch test，and the invasion ability of MCF-7 cells in each group was detected by Transwell invasion test.Results　The relative expression of miR-152-3p in the breast cancer tissues was significantly lower than that in the normal breast tissues，and the relative expression of PIK3CA mRNA in the breast cancer tissues was significantly higher than that in the normal breast tissue (P< 0.05).The relative expression of miR-152-3p in MCF-7 cells was significantly lower than that in MCF-10A cells，and the relative expression of PIK3CA mRNA in MCF-7 cells was significantly higher than that in MCF-10A cells (P<0.05).Compared with the blank group and the negative control group，the relative expression of PIK3CA，p38，ERK，JNK and E-cadherin protein in MCF-7 cells in the miR-152-3p mimic group and si-PIK3CA group decreased significantly，while the relative expression of PIK3CA，p38，ERK，JNK and E-cadherin protein in MCF-7 cells in miR-152-3p inhibitor group increased significantly (P<0.05).There was no significant difference in the relative expression of PIK3CA，p38，ERK，JNK and E-cadherin protein between the miR-152-3p inhibitor+si-PIK3CA group and the blank group and the negative control group (P>0.05).The experimental results of cell proliferation showed that the proliferation of MCF-7 cells in the miR-152-3p mimic group and si-PIK3CA group was significantly lower than that in the blank group and negative control group，and the proliferation of MCF-7 cells in miR-152-3p inhibitor group was significantly higher than that in the blank group and negative control group (P<0.05)，but there was no significant difference in MCF-7 cell proliferation between the miR-152-3p inhibitor+si-pik3ca group and the blank group or the negative control group at 48，72 and 96 hours (P> 0.05).The results of scratch test and Transwell invasion experiment showed that there was no significant difference in the migration and invasion ability of MCF-7 cells between the blank group and the negative control group (P>0.05).Compared with the blank group and the negative control group，the migration and invasion ability of of MCF-7 cells in the miR-152-3p mimic group and si-PIK3CA group decreased significantly，while that in the miR-152-3p inhibitor group increased significantly (P<0.05).There was no significant difference in the migration and invasion ability of MCF-7 cells between the miR-152-3p inhibitor+si-PIK3CA group and the blank group or negative control group (P>0.05).Conclusion　The expression of miR-152-3p is down regulated in breast cancer tissues，which may be involved in the occurrence and development of breast cancer.MiR-152-3p may inhibit the activation of MAPK signal pathway by inhibiting the expression of PIK3CA，and then inhibit the growth，proliferation，invasion and metastasis of breast cancer cells.

参考文献/References:

［1］　ZUO T T，ZHENG R S，ZENG H M，et al.Female breast cancer incidence and mortality in China，2013［J］.Thorac Cancer，2017，8(3):214-218.
［2］　牛四明，罗欢欢.新辅助化学治疗联合手术治疗局部晚期乳腺癌疗效观察［J］.新乡医学院学报，2017，34（5）：429-431.
［3］　RUPAIMOOLE R，SLACK F J.MicroRNA therapeutics: towards a new era for the management of cancer and other diseases［J］.Nat Rev Drug Discov，2017，16(3):203-222.
［4］　王天有，陆继冉，郑胡镛.儿童血液肿瘤靶向治疗新进展［J］.中华实用儿科临床杂志，2017，32（3）：161-167.
［5］　FENG A，YUAN X，LI X.MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1［J］.Oncol Rep，2017，38(5):2752-2760.
［6］　何建苗，赵华洲，王婷，等.miR-181a-5p靶向Kras对乳腺癌细胞 MDA-MB-231增殖及凋亡的调控作用［J］.解放军医学杂志，2018,43（9）：735-739.
［7］　ZHANG A，LAKSHMANAN J，MOTAMENI A，et al.MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA，p38 MAPK，c-Jun，and GSK3 signaling［J］.Mol Cell Biochem，2018，441(1/2):89-98.
［8］　杨宁，郭妹，宋玉兰，等.430例中国非小细胞肺癌患者EGFR、KRAS、BRAF和PIK3CA基因突变状态及其临床意义［J］.中国肿瘤生物治疗杂志，2015，22（6）：734-739.
［9］　BGER C，KRGER S，BEHRENS H M，et al.Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations［J］.Ann Oncol，2017，28(5):1005-1014.
［10］　汪毅，袁伟，马肖，等.MiR-152在结直肠癌组织中的表达及其与预后的关系［J］.中华肿瘤杂志，2016，38（10）：763-766.
［11］　CHEN M J，CHENG Y M，CHEN C C，et al.MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM［J］.Biochem Biophys Res Commun，2017，483(2):840-846.
［12］　DENG H，LV L，LI Y，et al.MiR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway［J］.Mol Cancer，2014，13(1)：234-240.
［13］　JIANG L P，HE C Y，ZHU Z T.Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene［J］.Oncotarget，2017，8(14)：23675-23689.
［14］　李海龙，宋耀辉，陈兆峰，等.MiR-20a-5p/miR-20b-5p在胃癌细胞和组织中的表达及调控靶基因信号通路富集分析［J］.临床检验杂志，2017，35（11）：822-827.
［15］　WEI C H，WU G，CAI Q，et al.MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway［J］.J Hematol Oncol，2017，10(1):125-126.
［16］　黄志华，孙红.MiR-424和miR-503介导的MAPK信号通路调节卵巢上皮性癌细胞增殖及迁移的作用及其机制［J］.中华妇产科杂志，2017，52（10）：704-707.
［17］　LI Z H，LI L，KANG L P，et al.MicroRNA-92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer［J］.Cancer Med，2018，7(7):3118-3131.
［18］　EISOLD M，ASIM M，ESKELINEN H，et al.Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens［J］.J Mol Endocrinol，2009，42(5):429-435.
［19］　SUKHTANKAR D，OKUN A，CHANDRAMOULI A，et al.Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain［J］.Mol Pain，2011，7(1):81-96.

相似文献/References:

[1]张光谋,吴俊琢,徐振平,等.抗细胞凋亡基因bcl一2在乳腺癌中的表达[J].新乡医学院学报,2001,18(03):160.
[2]刘玉生 ． 万里,李森恺.乳腺癌切除即期乳房再造[J].新乡医学院学报,2001,18(01):023.
[3]王承正,张锦瑜,邱树升,等.C—erbB一2与ER、PS一2在乳腺癌中的表达及其临床相关性[J].新乡医学院学报,2003,20(05):324.
[4]王承正,张锦瑜,邱树升,等.C2erbB22 与ER、PS22 在乳腺癌中的表达及其临床相关性[J].新乡医学院学报,2003,20(05):324.
[5]王志民,段西华,祁天义,等.多点皮瓣固定法预防乳腺癌术后皮下积液效果观察 [J].新乡医学院学报,2007,24(03):287.
[6]郭兰青.乳腺癌患者生活质量影响因素[J].新乡医学院学报,2008,25(06):637.
[7]曹兴玥,赵庆伟,靳艳,等.CD44和nm23在乳腺浸润性导管癌中的表达及其与淋巴结转移的关系[J].新乡医学院学报,2011,28(01):042.
[8]靳艳,曹兴玥,赵庆伟,等.CD62P在人乳腺癌组织中的表达及其与淋巴结转移的关系[J].新乡医学院学报,2011,28(01):045.
[9]王　乐,王静萱,张清媛.乳腺癌骨转移靶向治疗进展[J].新乡医学院学报,2015,32(09):887.
[10]杨绍英,刘朝荣,张志刚,等.乳腺癌新辅助化学治疗前后雌激素受体、乳激素受体、Ki-67抗原和人类表皮生长因子受体-2的表达[J].新乡医学院学报,2017,34(2):125.[doi:10.7683/xxyxyxb.2017.02.012]
　YANG Shao-ying,LIU Chao-rong,ZHANG Zhi-gang,et al.Expressions of estrogen receptor，progestin recetor，Ki-67 antigen，and human epidermal growth factor receptor 2 before and after neoadjuvant chemotherapy in patients with breast cancer[J].Journal of Xinxiang Medical University,2017,34(12):125.[doi:10.7683/xxyxyxb.2017.02.012]

更新日期/Last Update: 2019-12-05